1-3 of 3
I. Jolanda de Vries
Close
Sort by
Journal Articles

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Zwi N. Berneman, MD, PhD, Ann an de Velde, MD, Sébastien Anguille, MD, Nathalie Cools, PhD, Ann Van Driessche, MSc, Katrien Vermeulen, PhD, Katrien Pieters, PhD, Griet Nijs, MT, Barbara Stein, MSc, Evelien L. Smits, PhD, Wilfried A. Schroyens, MD, PhD, Alain P. Gadisseur, MD, PhD, Inge Vrelust, MD, I. Jolanda de Vries, PhD, Kristin Ladell, PhD, Emma Gostick, PhD, David A. Price, MD, PhD, Yusuke Oji, MD, PhD, Yoshihiro Oka, MD, PhD, Haruo Sugiyama, MD, PhD, Viggo F. Van Tendeloo, PhD
Journal: Blood
Blood (2010) 116 (21): 16.
https://doi.org/10.1182/blood.V116.21.16.16
Published: 2010
Journal Articles

Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia

Zwi N. Berneman, Ann Van de Velde, Ann Van Driessche, Nathalie Cools, Barbara Stein, Griet Nijs, Katrien Vermeulen, Katrien Pieters, Wilfried A. Schroyens, Alain P. Gadisseur, Inge Vrelust, I. Jolanda de Vries, David A. Price, Yusuke Oji, Haruo Sugiyama, Viggo F. Van Tendeloo
Journal: Blood
Blood (2008) 112 (11): 830.
https://doi.org/10.1182/blood.V112.11.830.830
Published: 2008
Journal Articles

Vaccination of Acute Myeloid Leukemia Patients with Dendritic Cells Electroporated with mRNA Encoding the Wilms’ Tumor Protein WT1: A Phase I/II Trial.

Zwi N. Berneman, MD, PhD, Ann Van Driessche, M.Sc., Ann Van de Velde, M.D., Griet Nijs, M.T., Tessa Braeckman, M.Sc., Barbara Stein, M.Sc, Katrien Vermeulen, Ph.D., Katrien Pieters, Ph.D., Alain P. Gadisseur, M.D., Ph.D, Wilfried A. Schroyens, M.D., Ph.D., I. Jolanda de Vries, Ph.D., David A. Price, Ph.D., Viggo F. Van Tendeloo, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 158.
https://doi.org/10.1182/blood.V110.11.158.158
Published: 2007